VYVGART & VYVGART Hytrulo
VYVGART (efgartigimod alfa-fcab) is a treatment that uses a fragment of an IgG antibody to treat adults with anti-AChR antibody positive generalized myasthenia gravis (gMG). VYVGART Hytrulo is a combination of efgartigimod alfa, a neonatal Fc receptor blocker, and hyaluronidase, an endoglycosidase, indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who […]
VYEPTI
VYEPTI (eptinezumab-jjmr) is a calcitonin-gene-related peptide antagonist (CGRP) inhibitor that is used to prevent migraines in adults. VYEPTI was approved for use by the Food and Drug administration (FDA) in February 2020 and became available in April. For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if […]
UPLIZNA
UPLIZNA (inebilizumab-cdon) is a prescription medicine used to treat neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive. For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you. UPLIZNA REFERRAL FORM
SOLU-MEDROL
SOLU-MEDROL (methylprednisolone 21) is a steroid often used for flare-ups in patients with Multiple Sclerosis (MS) or infused with other medications to treat MS. SOLU-MEDROL works by preventing the release of certain substances in the body that can cause inflammation. For more information, visit the patient website for this drug. Speak with your healthcare provider […]
SOLIRIS
SOLIRIS (eculizumab) is a monoclonal antibody that binds to proteins in the blood that can destroy red blood cells. Specifically, it is a complement inhibitor antibody used to treat myasthenia gravis and certain hemolytic (blood-related) syndromes. For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this […]
QUTENZA®
QUTENZA® (capsaicin) 8% topical system is indicated in adults for the treatment of neuropathic pain associated with postherpetic neuralgia (PHN) and for neuropathic pain associated with diabetic peripheral neuropathy (DPN) of the feet. For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for […]
OCREVUS
OCREVUS (ocrelizumab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells. This may help to protect healthy cells from damage. Specifically, it is a CD20-cytolytic antibody for the treatment of Multiple Sclerosis (MS). For more information, visit the patient website for this drug. Speak with your healthcare provider […]
LEQEMBI
LEQEMBI (lecanemab-irmb) is an amyloid beta-directed antibody indicated for treating Alzheimer’s disease. LEQEMBI is intended to treat patients with mild cognitive impairment or experiencing the mild dementia stage of the disease. For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you. […]
Kisunla
Kisunla (donanemab-azbt) treatment for early symptomatic Alzheimer’s Disease, which includes mild cognitive impairment (MCI) or mild dementia stage of disease. For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you. KISUNLA REFERRAL FORM
GAMUNEX-C
GAMUNEX-C (immune globulin injection (human) 10%) is an immune globulin (IG) made from human blood plasma. Like other IG products, GAMUNEX-C contains antibodies. Specifically, it is an immune globulin (human 10% caprylate/chromatography purified) for the treatment of primary humoral immunodeficiency (PI) in patients 2 years and older, idiopathic thrombocytopenic purpura (ITP), and chronic inflammatory demyelinating […]